Tuesday, 19 Sept 2023 06:00 PM - 07:30 PM Central Time ( US & Canada)
1.0 RAC Credit
This hybrid session will address FDA regulatory law topics on Digital Health, including navigating topics related to clinical decision support, software functions, artificial intelligence/machine learning, and cybersecurity. Including, how Digital Health companies can stay outside the realm of FDA oversight. The session will also focus on recent Digital Health policy updates, including how Digital Health may impact an update to the medical device statutory scheme.
Click here to register today!
------------------------------
Danielle Pennant
Chapter Events Coordinator
------------------------------